Torleif Roykenes

Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.

Man Investments (CH) AG (Man Investments) is the Switzerland-based asset management subsidiary of Man Strategic Holdings Plc, itself a subsidiary of Man Group Plc (LSE: EMG) in Great Britain. Established in 1994, the firm is dedicated solely to alternative investing, offering investors access to a wide range of hedge fund portfolios that target strong, stable capital growth through the market cycle. In 2009 Man Group launched a new investment management business uniting Man's scale and expertise in hedge fund investing with the strengths of RMF Investment Management 's infrastructure and disciplined investment process and Glenwood Capital Investments' proven bottom-up manager selection philosophy. Headquartered in Pfaffikon, Man Investments provides transparent access to hedge fund investing through fund of fund portfolios and customized solutions for institutional and private investors.

HeiQ Materials AG develops and manufactures antimicrobial silver and other sustainable textile effects. It offers textile brands innovation research and development, customized chemical manufacturing, and ingredient branding in one. The company was founded by Carlo Centonze and Murray Height in 2005 and is headquartered in Schlieren, Switzerland.

Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland.

Credit Suisse Entrepreneur Capital AG (formerly SVC AG für KMU Risikokapital) provides venture capital services for Swiss small and medium enterprises. The company invests in existing businesses, start-up businesses and small-scale businesses. It was founded in 2010 and is headquartered in Zurich, Switzerland.

TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then.

Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019.

Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation.